Alpha 2 Agonists for Sedation to produce Better Outcomes from Critical Illness (A2B TRIAL): A Parallel Group Randomised Controlled Trial Comparing Clonidine, Dexmedetomidine and Current Usual Care

Norrie, John (Principal Investigator)
Parker, Richard (Co-investigator)
Weir, Christopher (Co-investigator)

Deanery of Molecular, Genetic and Population Health Sciences

Status	Finished
Effective start/end date	1/04/18 → 31/12/21

Funding

Other: £1,354,866.00

1 Article

Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): Protocol for a mixed methods process evaluation of a randomised controlled trial
Aitken, L. M., Emerson, L. M., Kydonaki, K., Blackwood, B., Creagh-Brown, B., Lone, N. I., McKenzie, C., Reade, M. C., Weir, C. J., Wise, M. P. & Walsh, T. S., 5 Apr 2024, In: BMJ Open. 14, 4, 7 p., e081637.
Research output: Contribution to journal › Article › peer-review

Open Access
File